MORGAN WESNER: Open Payments
NPI 1225728066 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 14 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $280 · 2025 $468
Food & beverage: $371Education: $97
| Company | Payments | Amount |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 6 | $249 |
| Novartis Pharmaceuticals Corporation | 3 | $92 |
| Mallinckrodt Hospital Products Inc. | 2 | $41 |
| Apellis Pharmaceuticals, Inc. | 1 | $34 |
| Travere Therapeutics, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
Products named: ENVARSUS, Fabhalta, TERLIVAZ, LIVTENCITY.
Industry payments across TX — which companies pay providers there.
